Abstract:The diterpenoid paclitaxel (Taxol ® ) is a blockbuster anticancer agent that was originally isolated from the Pacific yew ( Taxus brevifolia ) five decades ago. Despite the wealth of information gained over the years on Taxol research, there still remains supply issues to meet increasing clinical demand. Although alternative Taxol production methods have been developed, they still face several drawbacks that cause supply shortages and high production costs. It is highly desired to develop biotechnological production platforms for Taxol, however, there are still gaps in our understanding of the biosynthetic pathway, catalytic enzymes, regulatory and control mechanisms that hamper production of this critical drug by synthetic biology approaches. Over the past 5 years, significant advances were made in metabolic engineering and optimization of the Taxol pathway in different hosts, leading to accumulation of taxane intermediates. Computational and experimental approaches were leveraged to gain mechanistic insights into the catalytic cycle of pathway enzymes and guide rational protein engineering efforts to improve catalytic fitness and substrate/product specificity, especially of the cytochrome P450s (CYP450s). Notable breakthroughs were also realized in engineering the pathway in plant hosts that are more promising in addressing the challenging CYP450 chemistry. Here, we review these recent advances and in addition, we summarize recent transcriptomic data sets of Taxus species and elicited culture cells, and give a bird’s-eye view of the information that can be gleaned from these publicly available resources. Recent mining of transcriptome data sets led to discovery of two putative pathway enzymes, provided many lead candidates for the missing steps and provided new insights on the regulatory mechanisms governing Taxol biosynthesis. All these inferences are relevant to future biotechnological production of Taxol.

Strategies in Taxol development. A review.

Taxol: biosynthesis, molecular genetics, and biotechnological applications

Morphological Characteristics, Geographical Distribution, Secondary Metabolites, and Biological Activities of Taxus

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Diverse strategic approaches en route to Taxol total synthesis

Strategies and Lessons Learned from Total Synthesis of Taxol

Recent Research Progress in Taxol Biosynthetic Pathway and Acylation Reactions Mediated by Taxus Acyltransferases

Asymmetric Total Synthesis of Taxol

Taxol Biosynthesis and Molecular Genetics

Biosynthesis of paclitaxel using synthetic biology

Plants against cancer: towards green Taxol production through pathway discovery and metabolic engineering

Biosynthesis of the highly oxygenated tetracyclic core skeleton of Taxol

Uncovering the Baccatin III Biosynthetic Pathway for Sustainable Taxoid Supply

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Drugs That Changed Society: Microtubule-Targeting Agents Belonging to Taxanoids, Macrolides and Non-Ribosomal Peptides

Research Progress of Paclitaxel Drug Source Solution and Extraction and Separation Technology

Characteristics, Properties and Analytical Methods of Paclitaxel: A Review

Innovative strategies for effective paclitaxel delivery: Recent developments and prospects

The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites

[Advances in paclitaxel biosynthesis and transcriptional regulation mechanisms]